SCHEMBL27919783

SCHEMBL27919783

COc1ccccc1C(C=O)Cc1cc(C)cc(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 4/20 0.39
ABCB1 P08183 1/20 0.38
IDH1 O75874 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
MMP1 P03956 1/20 0.35
NFE2L2 Q16236 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
HTR1A P08908 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9228226 0.80 TAAR1 (0.51) ABCB1L3MBTL1CHRM2CHRM1CHRM3
SCHEMBL9694621 0.76 CA1 (0.43) NPSR1L3MBTL1POLBHTTCHRM2
SCHEMBL6557136 0.74 POLB (0.41) NPSR1L3MBTL1POLBHTTCHRM2
SCHEMBL28070366 0.74 POLB (0.41) NPSR1L3MBTL1POLBHTTCHRM2
SCHEMBL28846739 0.74 CA1 (0.42) NPSR1L3MBTL1POLBHTTCHRM2
SCHEMBL27919782 0.73 ALDH1A1 (0.40) TACR1IDH1NPSR1L3MBTL1POLB
SCHEMBL28878316 0.70 TAAR1 (0.42) TACR1IDH1NPSR1L3MBTL1POLB
SCHEMBL8506771 0.70 CCNB2 (0.49) L3MBTL1CYP2C19MAPTMAPK1HTR1A
SCHEMBL28187870 0.70 HTT (0.47) HTTCYP2D6CYP2C19NFE2L2MAPK1
SCHEMBL15331984 0.68 CA1 (0.50) NPSR1L3MBTL1POLBHTTCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103339095-A Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators ALLERGAN INC 2013-10-02 CN disclosed